Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 27, 2010
Mon, July 26, 2010 Naked Short Web Site Announces ENAB, NEXM, MRWSY, CWLZ, MUNMF, MCLN Have Been Removed From Threshold Lists Today
July 26, 2010 /M2 PRESSWIRE/ BUYINS.NET, www.buyins.net , announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold lists. Enable Holdings (OTCBB: ENAB), NexMed (NASDAQ: NEXM), WM Morrisson Supermakets (OTC: MRWSY), Cowlitz Bancorp (OTC: CWLZ), Mundoro Capital (OTC: MUNMF) and MedClean Technologies (OTCBB: MCLN). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
Enable Holdings, Inc. (OTCBB: ENAB), through its subsidiaries, operates on-line Websites that enable itself, merchants, manufacturers, retailers, distributors, and small businesses to offer excess, new, overstock, close-out, refurbished, and limited supply brand name merchandise to consumer and business customers. The company, through its Websites, uBid.com and RedTag.com, offers merchandise across a range of product categories, including computer products, consumer electronics, apparel, house wares, watches, jewelry, travel, sporting goods, home improvement products, and collectibles using auction style and fixed price formats. It also serves customers through the traditional in-store sales and live liquidation sales. In addition, Enable Holdings provides business-to-business wholesale inventory liquidation services for manufacturers and distributors to sell large quantities of excess inventory, as well as licenses auction software to third party companies. The company, formerly known as uBid.com Holdings, Inc., was founded in 1997 and is based in Itasca, Illinois. There is no longer a failure to deliver in shares of ENAB.
NexMed, Inc. (NASDAQ: NEXM) engages in designing and developing pharmaceutical products based on its patented NexACT drug delivery technology. The NexACT drug delivery technology is designed to enhance the delivery of an active drug to improve therapeutic outcomes and reduce systemic side effects that accompany oral and injectable medications. The companya�s proprietary topical nail solution, NM100060, is a Phase III clinical trial product for the treatment of onychomycosis (nail fungal infection). Its products also include Vitaros, a Phase III clinical trial topical alprostadil-based cream treatment for patients with erectile dysfunction; and Femprox, a Phase II clinical trial alprostadil-based cream product for the treatment of female sexual arousal disorder. In addition, NexMed focuses on developing treatments for psoriasis, cancer inflammation, pain, and wound healing. Further, the company, through its subsidiary, Bio-Quant, Inc., operates as a specialty biotech contract research organization that provides services in the areas of non-good laboratory practices in vitro and in vivo contract drug discovery, as well as pre-clinical development services specializing in oncology, inflammation, immunology, and metabolic diseases. Bio-Quant, Inc. also conducts studies in the areas of in vitro and in vivo pharmacology, pharmacokinetics, and toxicology to support pre-investigational new drug enabling packages, as well as sells diagnostic kits. The company was founded in 1987 and is headquartered in San Diego, California. There is no longer a failure to deliver in shares of NEXM.
Wm Morrison Supermarkets PLC (OTC: MRWSY) operates retail supermarket stores in the United Kingdom. Its supermarkets offer fresh and frozen foods, fruits, vegetables, groceries, wines, spirits, and soft drinks, as well as health and pharmacy products, music and games, CDs and DVDs, garden products, and baby foods. As of February 1, 2009, it operated 382 stores. The company was founded in 1899 and is headquartered in Bradford, the United Kingdom. There is no longer a failure to deliver in shares of MRWSY.
Cowlitz Bancorporation (OTC: CWLZ) operates as the holding company for Cowlitz Bank that provides a range of financial services to small and medium-sized businesses, professionals, and retail customers. It offers various deposit products, including non-interest-bearing and interest-bearing checking, savings, money market, and individual retirement accounts, as well as certificates of deposit. The company also provides loan products comprising commercial loans, such as operating lines of credit to support accounts receivable and inventory, and secured term loans to finance machinery and equipment; real estate loans for construction, purchase, or refinancing of residential properties; and consumer loans that include secured and unsecured personal loans, home equity, personal lines of credit, and motor vehicle loans. In addition, it offers trust services to individuals, partnerships, corporations, and institutions, as well as operates as a fiduciary for living trusts, estates, conservatorships, and other plans. Further, the company provides international banking services, such as commercial and standby letters of credit, foreign exchange and foreign collection services, international funds transfer capabilities, accounts receivable financing, and foreign denominated accounts; Internet banking services, which provide access to information and services from the Website; and other banking products and services, such as debit card programs, automated teller machines, merchant services, and automated telephone banking services. Additionally, it offers mortgage banking services through its offices in Longview and Vancouver, Washington. The company operates four branches in Cowlitz County in southwest Washington. It operates branches under the name Bay Bank in Bellevue, Seattle, and Vancouver, Washington; Portland, Oregon; and a limited service branch in a retirement center in Wilsonville, Oregon. The company was founded in 1978 and is based in Longview, Washington. There is no longer a failure to deliver in shares of CWLZ.
Mundoro Capital Inc. (OTC: MUNMF) operates as a mineral exploration, development, and investment company. The company, through its subsidiary, Mundoro Mining Inc., focuses on the exploration and development of gold on its principal project, the Maoling Gold Project, which is located in Liaoning province, the Peoplea�s Republic of China. Mundoro Capital is headquartered in Vancouver, Canada. There is no longer a failure to deliver in shares of MUNMF.
Medclean Technologies, Inc. (OTCBB: MCLN) designs, sells, installs, and services on site turnkey systems to treat regulated medical waste. It provides MedClean series systems as solutions to incineration and off site hauling of untreated waste, and other alternative treatment technologies and methodologies. The companya�s MedClean system employs various equipment and machinery, including an autoclave vessel to sterilize the medical waste; the MedClean Shredder to convert sterilized waste material into non-recognizable confetti-like material qualifying the end product as safe municipal solid waste; AutoTouch control station with software and hardware components that integrate and bundle operating and data recording functions into a system for conversion and disposal of medical waste; a material transporter to mechanically transport the processed waste from shredder to the municipal solid waste compacting dumpster; and a QuietCart transport cart system to facilitate a single source containerization of the infectious waste from generation, sterilization, processing, and return for refill. It markets its MedClean systems directly to waste generators, such as hospitals, nursing homes, clinics, medical groups, health departments, laboratories, physicians, dentists, and veterinarians in private practice. The company was formerly known as Aduromed Industries, Inc. and changed its name to MedClean Technologies, Inc. in January 2009. Medclean Technologies, Inc. is based in Bethel, Connecticut. There is no longer a failure to deliver in shares of MCLN.
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,750,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net
- WOPRAI
- support@woprai.com